July 15, 2025 By Ashley Tucker, OD, FAAO, FSLS, ABO Diplomate The 2025 update by Brennan et al., published in Contact Lens...
June 16, 2025 By Caroline Kaufman, OD, IACMM My journey in optometry began over 30 years ago, with the last 20 years...
sponsored content June 16, 2025 By Dr. Bryan Sim, Consultant Ophthalmologist, Myopia Service, Singapore National Eye Centre (SNEC) Introduction: Addressing the Challenge...
June 6, 2025 DEL MAR, Calif. — Sydnexis‘ proprietary low-dose atropine formulation, SYD-101, has received marketing authorization from the European Commission (EC)....
June 4, 2025 SALT LAKE CITY — iVeena Delivery Systems has submitted an investigational new drug (IND) application to the U.S. Food...
sponsored content June 2, 2025 By Debbie Jones, FCOptom, FAAO, FBCLA, and Monica Jong, OD, PhD, FBCLA As eye care professionals embrace...
May 15, 2025 By Jason Compton, OD When I graduated optometry school in 2005, myopia management wasn’t a well-known specialty. However, as...
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May 4-8, 2025....
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May 4-8, 2025....
The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May...
May 1, 2025 By Mahmoud Haddara, BSc, OD The use of topical low-dose atropine to slow progression in myopic children is well...
May 1, 2025 By Dr. Loren Rose The management of progressive myopia in young children has many specific challenges. Special considerations include,...
April 15, 2025 By Syafiq Kusni Over the course of the last decade, my optometry training has taken me from Singapore to...
BHVI’s Myopia Calculator is the first online toolkit designed to help eye care practitioners effectively communicate projected myopia progression and treatment efficacy...
April 2, 2025 DEL MAR, Calif. — Sydnexis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
April 1, 2025 By Aamena Kazmi, OD, ABO Diplomate As myopia prevalence increases globally, collaborative relationships with ophthalmologists and optometrists is essential...
March 17, 2025 By Michael Lipson, OD, and Bruce Koffler, MD The following is the second of two articles on the assessment...
March 11, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for...
March 3, 2025 By Dwight Barnes, OD, FIAOMC, IACMM Myopia management has grown substantially in recent years, from a relatively uncommon treatment...
March 3, 2025 By Associate Professor Pauline Kang, BOptom, PhD, School of Optometry and Vision Science at UNSW in Sydney, Australia As...
February 18, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE Yum et al. investigated the synergistic effect of dual-focus...
February 3, 2025 By Erica Barclay, OD The International Myopia Institute has defined pre-myopia as “a refractive state of an eye of...
February 3, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE The study “Efficacy and Safety of Different Atropine Regimens...
February 3, 2025 By Eman Alzghoul, PhD, FIACLE, FBCLA Adult myopia progression is commonly observed in clinical practice, yet there is a...
January 2, 2025 By Leila Sara Eppenberger, MD, FEBO, FMH, MSc ETH Over the past few decades, the options for controlling myopia...
sponsored content December 16, 2024 Privately held, clinical-stage pharmaceutical company, Sydnexis Inc. has recently completed an evaluation of its patented low-dose atropine...
December 9, 2024 MARKHAM, Ontario, Canada – On Sunday, December 8, leaders in the eye care field gathered here for THE Myopia...